Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
January 07, 2010
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
Cepheid's Xpert Flu A and Xpert vanA tests; Abbott's RealTime mS9 colorectal cancer test; Response Genetics' ResponseDX: Colon, ResponseDX: Lung, and ResponseDX: Gastric
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - Response Genetics Joins Blue Shield of California's Provider Network
May 16, 2013 / GenomeWeb Daily News - Cepheid Reports Q4, FY '12 Revenue Growth, but Looks to Address Issues from 'Challenging' Year
January 31, 2013 / PCR Insider - Piper Jaffray Downgrades Cepheid on Lingering Manufacturing Issues
January 4, 2013 / GenomeWeb Daily News